The 10% mindset and power of bold ideas | Prof. Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
A conversation with Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
A conversation with Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
Biotech may be global in ambition, but ecosystems thrive when capital arrives and stays.
A conversation with Dr. Uli Stilz, Head of Bio Innovation Hub at Novo Nordisk.
A conversation with Dr. Marina Gerner, journalist and author of The Vagina Business
Explore how to identify entrepreneurial academics in biotech using key metrics like startup leadership, patents, and research grants.
A conversation with Luke Timmerman, award-winning biotech journalist and founder of the Timmerman Report.
This report highlights the leading biotechnology venture capitalists in the Chicagoland area and provides an overview of its biotech investment landscape.
Brazilian VC funding in biotech is on the rise, with approximately 50 firms investing in a diverse range of biotech sectors.
Introduction to the Nucleate Biotech Ecosystem Insights Series.
The human story of biotechnology, and how it will change life as we know it.
A conversation with Armon Sharei, Founder & CEO at Portal
A deep dive into Denmark’s pharma-driven biotech boom and Norway’s eco-tech pivot, featuring insights from Nordic industry leaders in Nucleate’s Hidden Layers × Inside Global Life Sciences series.
A conversation with Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
A conversation with Armand Cognetta, CEO & founder of General Proximity
Biotech may be global in ambition, but ecosystems thrive when capital arrives and stays.
A conversation with Hilary Schultz and Dr. William Heath, CEO and CSO at Persephoni BioPartners